go back

Melanoma Versus Benign Mole Gene Test

Arkansas rates for HCPCS 0314U

Helps decide whether a skin lesion is a melanoma or a harmless mole when its appearance under the microscope is not clear cut. The activity of 35 genes is measured in the stored tissue sample and the lesion is classified accordingly. A companion test instead judges the outlook for squamous cell skin cancers.

Rates data updated July 2026.

Facilitymedian $2,455 · 10th–90th $1,950$3,3880%50%10th90th$2,455Professionalmedian $1,698 · 10th–90th $1,175$2,4550%20%10th90th$1,698$1.0K$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,454.71
Median
$2,454.71
Typical High
$3,388.44
Aetna
Setting
Professional
Modifier
Global
Typical Low
$1,174.90
Median
$1,698.24
Typical High
$2,454.71
BCBS
Setting
Professional
Modifier
Global
Typical Low
$1,737.80
Median
$1,737.80
Typical High
$2,630.27
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,548.82
Median
$1,659.59
Typical High
$3,630.78
United
Setting
Facility
Modifier
Global
Typical Low
$1,737.80
Median
$1,737.80
Typical High
$2,238.72
United
Setting
Professional
Modifier
Global
Typical Low
$812.83
Median
$1,174.90
Typical High
$1,949.84